• Exchange: FN Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

PledPharma AB

+ Add to Watchlist

PLED:SS

15.3000 SEK 0.3000 2.00%

As of 07:30:00 ET on 04/17/2014.

Snapshot for PledPharma AB (PLED)

Open: 14.4000 Day's Range: 14.4000 - 15.3000 Volume: 61
Previous Close: 15.0000 52wk Range: 10.8942 - 23.6617 1-Yr Rtn: +38.10%

Stock Chart for PLED

No chart data available.
  • PLED:SS 15.3000
  • 1D
  • 1M
  • 1Y
15.0000
Interactive PLED Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PLED

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 9.6226
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -1.1885
Est. EPS (SEK) (12/2014) 1.5900
Est. PEG Ratio -
Market Cap (M SEK) 361.42
Shares Outstanding (M) 23.62
30 Day Average Volume 19,470
Price/Book (mrq) 6.3138
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PLED

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for PLED

PledPharma AB researches pharmaceuticals. The Company develops cardiology and oncology drugs. PledPharma researches pyridoxyl ethyldiamine derivatives which mimic manganese superoxide dismutase (MnSOD). MnSOD protects mammalian cells from the superoxide radical.

Jacques NaesstroemChief Executive OfficerMarie BengtsonDirector:Clinical Project
Michaela Johansson GertzChief Financial OfficerSven JacobssonDirector:Manufacturing/Ctrl
More Company Profile & Key Executives for PLED

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil